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 We have reported that microRNAs (miRNAs, miRs) in bovine milk regulate 
human genes. In milk, many miRNAs are encapsulated in exosomes, thereby conferring 
protection against degradation and a pathway for intestinal transport of miRNAs. We 
hypothesized that the uptake of bovine exosomes in human intestinal colon carcinoma 
Caco-2 cells and rat primary small intestinal IEC-6 cells is mediated by endocytosis. 
Transport studies were carried out using fluorophore-labeled exosomes purified from 
bovine milk. The transport of bovine exosomes exhibited saturation kinetics at 37°C 
(Km= 55.5±48.6 µg/200 µL, Vmax= 0.083±0.057 ng exosomal protein x 81,750 cells
−1 x 
hr−1) and decreased by 60% if transport was measured at 4°C in Caco-2 cells, consistent 
with carrier-mediated transport. Inhibitors of vesicle trafficking and carbohydrate 
competitors caused a 62-85% and 61-83% decrease, respectively, in exosome transport, 
consistent with cellular transport of bovine exosomes by endocytosis that depends on 
surface glycoproteins in Caco-2 cells. Similar patterns were observed in IEC-6 cells. 
When milk exosomes at a concentration of five times the Km were added to the upper 
chamber in transwell plates, Caco-2 cells accumulated miR-29b in the lower chamber, 
whereas reverse transport was minor.  We conclude that the uptake of bovine milk 
  
exosomes is mediated by endocytosis and depends on cell and exosome surface 
glycoproteins in human and rat intestinal cells.
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CHAPTER 1 
LITERATURE REVIEW 
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Extracellular Vesicles  
 
. Extracellular vesicles (EVs) are secreted by the plasma membrane (1) and range 30-1000 
nm in size (2). They are released from many cell types, such as epithelial cells (3), tumor 
cells (4), and neurons (5). Post-transciption modications (6), intercellular communcation 
(7), and exchange of genetic material in both eukaryote and prokarytoic cell types (8, 9) 
are just a few of the notable functional capablities of EVs. These membrane inclosed 
vesicles are spherical in shape (10), and when mounted for negative staining to be viewed 
by transmission electron microscopy (TEM), they appear cup-shapped (1, 11).  
 
History and Mechanism of Action 
 
 EVs are found in many biologial fluids, such as urine (12, 13), blood (14), salvia 
(15), and breast milk  (16). The major catergories of EVs include exosomes, 
microvesicles, and apopotoic bodies (Table 1). Table 1 summarizes the main differences 
between them.  
  In 1967, Peter Wolf visualized EVs with electron microscopy and described the 
vesicles as platlet dust while doing coagulation  research (17). By 1971 one of Wolf’s 
collegues used electron micrographs to visualize EVs from pig plasma which he 
described as having a “heterogenous granular“ apppearance (18) . Using 
ultracentrfiguation, George et al. in 1982 analyzed the microvesicles populations in the 
resulting pellets of human sera and plasma with an immunoelectrophoretic assay. They 
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discovered circulating micropartices originate from elsewhere in the human body, not just 
blood platelets as initially thought (19). Research progress has discovered a role for EVs 
in intracellular and extracellular communication (1, 7), immune response (7, 20, 21) and 
the delivery of exogenous compounds to recepient cells (8, 22, 23). For the purposes of 
this review, the primary focus will be exosomes. 
 
Table 1. Characteristics of different eukaryotic types of 
 cell derived extracellular vesicles 
Vesicles: Exosome  Microvesicles 
(Ectosomes) 
 
 
 Apoptotic bodies 
Diameter 
(nm) 
 
30-150   100-1,000    50-5000 
Density 
(g/ml) 
 
1.13-1.19   Unknown   Unknown 
Formation 
 
Exocytosis of 
MVBs  
 Budding of 
plasma 
membrane 
  Release from 
dying/apoptotic 
cells 
Morphology  
(TEM) 
Cup-shaped  Irregular 
shape 
  Heterogeneous  
 
Origin  Endosomes  Plasma 
membrane 
  Blebs released from 
cells undergoing 
apoptosis 
Protein 
Enrichment 
C81, CD63, CD9, 
LAMP1, Alix, 
TSG101  
 MMP2, 
Annexin V, 
integrins, 
selectins, 
CD40 ligands 
 
  Histones, Annexin 
V 
Adapted from (1, 11, 24-33) 
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Exosomes 
 
 
 The literature is well established that many cell types shed small vesicles into the 
extracelluar space. Exosomes are a type of extracellular vesicles that are secreted from 
various cells types by multivesicular bodies (MVBs) fusing with the plasma membrane 
(25, 32, 33). Endosomal exosome biogensis occurs by the inward budding of the plasma 
membrane into multivesicular bodies (MVBs). Johnston et al. proposed the term exosome 
be given to EVs that originate from MVBs (34). According to the International Society 
for Extracellular Vesicles, the term exosomes is the most popular word used to classify 
any type of extracellular vesicle (35). 
 Exosomes range 30-150 nm in sizes and mediate the transfer of microRNA 
between cells (30, 31, 36). Raposo et al. demonstrated B cell lymphocyte exosomes play 
a role in extracelluar commication by eliciting specific T cell responses (1). Dedendritic 
cell-derived exosomes can diminish the establishment of murine tumors, reinforcing their 
role in immune response (7). Numerous other studies have demonstrated the role of 
exosomes in cell to cell signaling activities (37, 38). 
Composition  
 Exosomes are enriched in proteins, and as a result have been associated with 
specific proteins for indication of their presence. Identification of exosomes became more 
appart when proteins that are involved with MVB biogensis were detected in exosomes 
(7, 39). Currently, over 4,500 proteins have been identified in exosomes (40). Eight major 
proteins have been identifited from murine dendritic derived exosomes, with heat shock 
cognate protein 73 (hsc73) being adundant and shown to accumulate in the endocytic 
5 
 
 
compartments of a murine spleen-derived cell line (41). According to ExoCarta, CD63 is 
among the top 25 proteins that are often identified in exosomes (42). Other proteins 
commonly used to identify exosomes include heat shock 70kDA protein 8 (HSPA8), 
CD9, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta-actin (ACTB), CD81 
and annexin A2 (ANXA2) (40). Though exosomes are enriched in many proteins, 
additional research is needed to distinguish between exosomes and microvesicles if trying 
to obtain pure isolates.  
 The lipid content of exosomes has not been studied as intensely as protein. Thus 
far, studies that focus on exosomes secreted from cells contain saturated fatty acids, 
cholesterol (43, 44),  posphytileserine, and sphingomyelin (44, 45).  
Transportation of Exosomes  
 The research suggests that cellular uptake of exosomes is mediated by an 
endocytosis-dependent process (46-48) including phagocytosis (49), receptor-mediated 
endocytosis (50), micropinocytosis (51) and macropinocytosis (see Figure 1.1) (52). 
According to Tan et al., mescnehymal stem cell released exosomes from an endocytosed 
lipid raft, suggesting their endosomal origin (53).  
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Figure 1.1 Simplified uptake pathways for extracellular vesicles 
[Figure source: Review by Mulcahy et al., 2014] (52) 
 How milk exosomes cross the intestinal muscosa needs further exploration, but 
one can infer that it might be similar to human EVs. Recently, an independent laboratory 
suggested that milk exosomes enter the mouse circulation intact by crossing the intestinal 
mucosa without re-packaging (54). Exosomes secreted by mast cells that contain mRNA 
and miRNA can be transferred to nearby cells and be operational (8, 55).  
  Rab proteins are small cytostolic GTPases that are known to control important 
steps in vesicle formation and trafficking (56). As a result, exosomes of endosomal origin 
contain proteins that are involved in membrane transport and fusion processes (see Figure 
1.2 B) (57). A group of the Rab proteins have been shown to be involved in exosome 
secretion. For instance, Rab35 is involved in transporting proteolipid protein from a 
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murine oligodendroglial cell MVBs to exosomes (58). The negative dominant mutant of 
Rab35 decreased exosomes release in an erythroleukemia cell line (59). Knock down of 
five Rab proteins: Rab27, Rab2b, Rab5a, Rab9a, and Rab27A, in HeLa cells inhibited 
exosomes secretion dramatically demonstrating their important role in exosomes 
secretion (60).   
 By using inhibitors of transport processes, researchers can gain insight on 
exosomes methods of entry and secretion from cells. According to Escrevente et al., 
treatment of ovarian tumor cells with the inhibitor cytochalasin D, resulted in a 36 +/- 
13% reduction in cell uptake of isolated labeled SKOV3 cell exosomes (61). A study 
using a transwell system treating Caco-2 cells with 10 uM of cytochalsin D caused nearly 
complete depolymerization of actin stress fibers (62). Guanine nucleotide exchange 
protein (BIG2) is a factor involved in ADP-ribosylation (63, 64). Brefeldin A has been 
shown to target ADP-ribosylation factor that is responsible for coat proteins associated 
with clathrin-coated vesicles (65).  
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Figure 1.2. Exosomes composition and extracellular vesicles origin of exosomes (a), 
ectosomes (b), and apoptotic bodies (c). 
 (B) Exosomes are composed RAB proteins, annexins ,adhesion molecules and 
tetraspanins, cytoskeletal proteins, and miRNA. Membranes are enriched in raft lipids 
such a cholesterol, spingolipids, and ceramide. Abbreviations: ALIX- apoptosis-linked 
gene 2-interacting protein X, ERM- ezrin radixin moesin, HSP70-Heat shock protein 70, 
TSG101- tumor susceptibility gene 101, ICAM- intercellular cell adhesion molecule. 
Figure adapted from Mittelbrunn et al., 2012 (57). 
 
Isolation of Extracellular Vesicles  
 The initial process used to isolate EVs was based on differential centriguation to 
remove vesicles larger than EVs (1, 7, 34). The final ultracentifugation step typically 
includes a G-force of at least 100,000 x g to pellet the exosomes (66). Centrifuge runs as 
high as 140,000 g has been used to sediment exosomes as well (67). To ensure that 
aggregates aren’t formed, some researchers use a sucrose cushion, where the aggrages 
sink though the sucrose, and the lipid containing EVs float on the correct density. 
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Exosomes float in sucrose gradients between the density of 1.13-1.19 g/mL (26). Though 
because this method is tedious, it’s losing popularity for exosome isolation since more 
convenient methods are currently being developed. Iodizanol Optiprep™  (Axis-Shield 
PoCAS) has recently been used with differnetial centrifugation to obtain more pure 
exosomes (68). Recent reports also suggest improved separation from apopototic bodies 
and viruses (69). Anti-body coated beads (HansaBioMed) and polymer based precipation 
kits (exoquick) are other methods that have become available for isolation of extracellular 
vesicles. An in-depth investigation of all methods of isolation for EVs is needed, as there 
is currently no gold standard recommendation for pure isolation of EVs.  
 
MicroRNA  
MicroRNAs are 19 to 25 nucleotides long (70, 71) noncoding RNAs, that typically bind 
to the 3’ UTR of target mRNAs leading to mRNA break down or translational delay (72, 
73). In the nucleus, microRNA is encoded by its own genes and transcribed by RNA 
polymerase II or RNA polymerase III (73, 74), followed by cleavage of the miRNA 
transcript by a complex called Drosha (75). The hairpin loop miRNA structure is then 
transported into the cytoplasm where the premature miRNA is further processed by dicer 
(76, 77), resulting in double stranded mature miRNA. The mature miRNA typically bind 
to the 3’ UTR of target mRNAs leading to mRNA break down or translational delay (72, 
73) (see Figure 1.3) (78). 
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Figure 1.3 The biogenesis of MicroRNA [Figure source: Joshi et al., 2011] (78) 
 Many mammalian microRNAs are found in introns or exons of long noncoding 
transcripts (73). Though the majority of human miRNAs are found 8937 intracellularly, 
they are also present in extracellular fluids such as cell culture supernatants (8, 55), urine 
(79), saliva (80), and milk (81). Extracellular miRNA in the plasma and serum has been 
found directly bound to Argonaute2 as part of the RISC complex (RNA induced silencing 
complex), which makes them resistant to degradation by exonucleases (82). In the 
plasma, miRNA has been shown to be delivered to cells by with high-density lipoproteins 
(83). 
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 A pivotal study in 2007 revealed that exosomes from MC/9, BMMC, and HMC-1 
cells contained a large amount of RNA, and miRCURY LNA Array detected 121 
microRNAs (8).  Many miRNAs can be found encapsulated in exosomes in human serum 
and saliva (84). MicroRNAs have also been detected in exosome originating from cells 
(55, 85, 86) and from malignant tumors (55). 
Bovine MicroRNA 
 In milk, many miRNAs are encapsulated in extracellular vesicles, such as 
exosomes, thereby conferring protection against degradation and a pathway for intestinal 
transport of miRNAs. MiR-29b is moderately abundant in cow’s milk, and plays a role in 
bone health (87). MiR-200c is highly abundant in cow’s milk, and plays a role in cancer 
prevention by causing dependent loss of transcription factor ZEB1 (88). MiR-29b 
stimulates osteoblast differentiation (89, 90), impairs osteoclast differentiation and as a 
result, promotes bone health through increasing bone mineral density (91). Recent studies 
have been conducted isolating exosomes from human and bovine milk that contain 
miRNA (92-94), as well as plants. Baier et al. was able to detect increased levels of miR-
200c and miR-29b after consumption of cow’s milk in human plasma (92).  
 
Other Dietary MicroRNA 
  The first report of plant miRNAs having the potential to modulate human genes 
was 3 years ago. Zang et al. high in rice, which contains miR-168a, could be detected in 
the human and animal sera (95). Thus far, other researchers have not been able to 
replicate their results (92, 96-99). In contrast to mammalian microRNAs, plant miRNAs 
are methylated at the 3’-terminal ribose by methyl transferase HEN1 (100). 
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 Farmer et al. recently showed that miR-2911 from honeysuckle was detected in 
mouse sera and urine after consumption (101). Human subjects fed broccoli sprouts had 
no detectable increase in broccoli borne miR-824 and miR-167a in human blood (92). 
Continued research in the microRNA research field is needed to confirm if dietary 
microRNAs can affect human health in physiological relevant concentrations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
 
References 
 
1. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, 
et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161-
72. Epub 1996/03/01. 
 
2. Jayachandran M, Miller VM, Heit JA, Owen WG. Methodology for isolation, 
identification and characterization of microvesicles in peripheral blood. J Immunol 
Methods. 2012;375(1-2):207-14. Epub 2011/11/15. 
 
3. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, 
et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 
2001;121(2):337-49. Epub 2001/08/07. 
 
4. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, et al. Tumor-
derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. 
Nat Med. 2001;7(3):297-303. Epub 2001/03/07. 
 
5. Faure J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B, et al. 
Exosomes are released by cultured cortical neurones. Molecular and cellular 
neurosciences. 2006;31(4):642-8. Epub 2006/02/01. 
 
6. van der Grein SG, Nolte-'t Hoen EN. "Small Talk" in the Innate Immune System 
via RNA-Containing Extracellular Vesicles. Frontiers in immunology. 2014;5:542. Epub 
2014/11/18. 
 
7. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, et al. 
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-
derived exosomes. Nat Med. 1998;4(5):594-600. Epub 1998/05/19. 
 
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-
mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange 
between cells. Nat Cell Biol. 2007;9(6):654-9. Epub 2007/05/09. 
 
9. Crescitelli R, Lasser C, Szabo TG, Kittel A, Eldh M, Dianzani I, et al. Distinct 
RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles 
and exosomes. Journal of extracellular vesicles. 2013;2. Epub 2013/11/14. 
 
10. Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle 
M, et al. Characterization and comprehensive proteome profiling of exosomes secreted 
by hepatocytes. Journal of proteome research. 2008;7(12):5157-66. Epub 2009/04/16. 
 
11. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. 
Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular 
14 
 
 
endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 
1998;273(32):20121-7. Epub 1998/08/01. 
 
12. Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, et al. Can urinary 
exosomes act as treatment response markers in prostate cancer? J Transl Med. 2009;7:4. 
Epub 2009/01/14. 
 
13. Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield 
XO, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for 
prostate cancer. Br J Cancer. 2009;100(10):1603-7. Epub 2009/04/30. 
 
14. Johnstone RM, Bianchini A, Teng K. Reticulocyte maturation and exosome 
release: transferrin receptor containing exosomes shows multiple plasma membrane 
functions. Blood. 1989;74(5):1844-51. Epub 1989/10/01. 
 
15. Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT. 
Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS 
ONE. 2010;5(1):e8577. Epub 2010/01/07. 
 
16. Lasser C, Alikhani VS, Ekstrom K, Eldh M, Paredes PT, Bossios A, et al. Human 
saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl 
Med. 2011;9:9. Epub 2011/01/18. 
 
17. Wolf P. The nature and significance of platelet products in human plasma. Br J 
Haematol. 1967;13(3):269-88. Epub 1967/05/01. 
 
18. Crawford N. The presence of contractile proteins in platelet microparticles 
isolated from human and animal platelet-free plasma. Br J Haematol. 1971;21(1):53-69. 
Epub 1971/07/01. 
 
19. George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet 
membrane microparticles from plasma and serum. Blood. 1982;60(4):834-40. Epub 
1982/10/01. 
 
20. Segura E, Amigorena S, Thery C. Mature dendritic cells secrete exosomes with 
strong ability to induce antigen-specific effector immune responses. Blood cells, 
molecules & diseases. 2005;35(2):89-93. Epub 2005/07/02. 
 
21. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, et al. Tumour-
released exosomes and their implications in cancer immunity. Cell death and 
differentiation. 2008;15(1):80-8. 
 
22. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, et al. Treatment of 
brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory 
drugs from the nasal region to the brain. Mol Ther. 2011;19(10):1769-79. Epub 
2011/09/15. 
15 
 
 
23. Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. 
Exosomes as drug delivery vehicles for Parkinson's disease therapy. Journal of controlled 
release : official journal of the Controlled Release Society. 2015;207:18-30. Epub 
2015/04/04. 
 
24. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, et al. Membrane 
vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life 
Sci. 2011;68(16):2667-88. Epub 2011/05/12. 
 
25. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and 
function. Nat Rev Immunol. 2002;2(8):569-79. Epub 2002/08/03. 
 
26. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune 
responses. Nat Rev Immunol. 2009;9(8):581-93. Epub 2009/06/06. 
 
27. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in 
intercellular communication. J Proteomics. 2010;73(10):1907-20. Epub 2010/07/06. 
 
28. Zhang HG, Grizzlet WE. Exosomes A Novel Pathway of Local and Distant 
Intercellular Communication that Facilitates the Growth and Metastasis of Neoplastic 
Lesions. American Journal of Pathology. 2014;184(1):28-41. 
 
29. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets 
release two types of membrane vesicles: microvesicles by surface shedding and 
exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 
1999;94(11):3791-9. Epub 1999/11/26. 
 
30. Llorente A, de Marco MC, Alonso MA. Caveolin-1 and MAL are located on 
prostasomes secreted by the prostate cancer PC-3 cell line. J Cell Sci. 2004;117(Pt 
22):5343-51. Epub 2004/10/07. 
 
31. Jansen FH, Krijgsveld J, van Rijswijk A, van den Bemd GJ, van den Berg MS, 
van Weerden WM, et al. Exosomal Secretion of Cytoplasmic Prostate Cancer Xenograft-
derived Proteins. Molecular & Cellular Proteomics. 2009;8(6):1192-205. 
 
32. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping 
extracellular messages. Curr Opin Cell Biol. 2004;16(4):415-21. Epub 2004/07/21. 
33. Lakkaraju A, Rodriguez-Boulan E. Itinerant exosomes: emerging roles in cell and 
tissue polarity. Trends Cell Biol. 2008;18(5):199-209. Epub 2008/04/09. 
 
34. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation 
during reticulocyte maturation. Association of plasma membrane activities with released 
vesicles (exosomes). J Biol Chem. 1987;262(19):9412-20. Epub 1987/07/05. 
 
35. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal 
experimental requirements for definition of extracellular vesicles and their functions: a 
16 
 
 
position statement from the International Society for Extracellular Vesicles. Journal of 
extracellular vesicles. 2014;3:26913. Epub 2014/12/30. 
 
36. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation 
of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol. 
2002;3(12):1156-62. Epub 2002/11/12. 
 
37. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, et al. 
Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer 
cell migration. Cell. 2012;151(7):1542-56. Epub 2012/12/25. 
 
38. Ristorcelli E, Beraud E, Mathieu S, Lombardo D, Verine A. Essential role of 
Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal 
nanoparticles. International Journal of Cancer. 2009;125(5):1016-26. 
 
39. Raiborg C, Rusten TE, Stenmark H. Protein sorting into multivesicular 
endosomes. Current Opinion in Cell Biology. 2003;15(4):446-55. 
 
40. Mathivanan S, Simpson RJ. ExoCarta: A compendium of exosomal proteins and 
RNA. Proteomics. 2009;9(21):4997-5000. Epub 2009/10/08. 
 
41. Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, et al. 
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of 
the heat shock protein hsc73. J Cell Biol. 1999;147(3):599-610. Epub 1999/11/05. 
 
42. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of 
exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012;40(Database issue):D1241-
4. Epub 2011/10/13. 
 
43. Llorente A, Skotland T, Sylvanne T, Kauhanen D, Rog T, Orlowski A, et al. 
Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Bba-Mol Cell 
Biol L. 2013;1831(7):1302-9. 
 
44. Wubbolts R, Leckie RS, Veenhuizen PTM, Schwarzmann G, Mobius W, 
Hoernschemeyer J, et al. Proteomic and biochemical analyses of human B cell-derived 
exosomes - Potential implications for their function and multivesicular body formation. 
Journal of Biological Chemistry. 2003;278(13):10963-72. 
 
45. Laulagnier K, Motta C, Hamdi S, Roy S, Fauvelle F, Pageaux JF, et al. Mast cell- 
and dendritic cell-derived exosomes display a specific lipid composition and an unusual 
membrane organization. Biochem J. 2004;380(Pt 1):161-71. Epub 2004/02/18. 
 
46. Tian T, Wang Y, Wang H, Zhu Z, Xiao Z. Visualizing of the cellular uptake and 
intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem. 
2010;111(2):488-96. Epub 2010/06/10. 
17 
 
 
47. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan MLG, Karlsson 
JM, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells 
via exosomes. Blood. 2012;119(3):756-66. 
 
48. Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, et al. Exosome Uptake 
through Clathrin-mediated Endocytosis and Macropinocytosis and Mediating miR-21 
Delivery. J Biol Chem. 2014;289(32):22258-67. Epub 2014/06/22. 
 
49. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, et al. Cellular 
internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675-87. 
Epub 2010/02/09. 
 
50. Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, 
et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. 
Blood. 2004;104(10):3257-66. Epub 2004/07/31. 
 
51. Fitzner D, Schnaars M, van Rossum D, Krishna  moorthy G, Dibaj P, Bakhti M, 
et al. Selective transfer of exosomes from oligodendrocytes to microglia by 
macropinocytosis. J Cell Sci. 2011;124(Pt 3):447-58. Epub 2011/01/19. 
 
52. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular 
vesicle uptake. Journal of extracellular vesicles. 2014;3. Epub 2014/08/22. 
 
53. Tan SS, Yin Y, Lee T, Lai RC, Yeo RW, Zhang B, et al. Therapeutic MSC 
exosomes are derived from lipid raft microdomains in the plasma membrane. Journal of 
extracellular vesicles. 2013;2. Epub 2013/12/29. 
 
54. Aqil F, Munagala R, Jeyabalan J, Gupta RC. Milk derived exosomes: scalable 
source of biologically active drug delivery nanoparticles [conference abstract: 5407]. 
Cancer Res. 2014;74(19 Supplement):5407. 
 
55. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. 
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and 
provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470-6. Epub 2008/11/18. 
 
56. Zerial M, McBride H. Rab proteins as membrane organizers (vol 2, pg 107, 
2001). Nat Rev Mol Cell Bio. 2001;2(3):216-. 
 
57. Mittelbrunn M, Sanchez-Madrid F. Intercellular communication: diverse 
structures for exchange of genetic information. Nat Rev Mol Cell Biol. 2012;13(5):328-
35. Epub 2012/04/19. 
 
58. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, 
et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins 
TBC1D10A-C. J Cell Biol. 2010;189(2):223-32. Epub 2010/04/21. 
18 
 
 
59. Savina A, Furlan M, Vidal M, Colombo MI. Exosome release is regulated by a 
calcium-dependent mechanism in K562 cells. Journal of Biological Chemistry. 
2003;278(22):20083-90. Epub 2003/03/18. 
 
60. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. 
Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell 
Biol. 2010;12(1):19-30; sup pp 1-13. Epub 2009/12/08. 
 
61. Escrevente C, Keller S, Altevogt P, Costa J. Interaction and uptake of exosomes 
by ovarian cancer cells. BMC Cancer. 2011;11:108. Epub 2011/03/29. 
 
62. Jackman MR, Shurety W, Ellis JA, Luzio JP. Inhibition of Apical but Not 
Basolateral Endocytosis of Ricin and Folate in Caco-2 Cells by Cytochalasin-D. Journal 
of cell science. 1994;107:2547-56. 
 
63. Jones HD, Moss J, Vaughan M. BIG1 and BIG2, brefeldin A-inhibited guanine 
nucleotide-exchange factors for ADP-ribosylation factors. Methods Enzymol. 
2005;404:174-84. Epub 2006/01/18. 
 
64. Islam A, Shen X, Hiroi T, Moss J, Vaughan M, Levine SJ. The brefeldin A-
inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of 
TNFR1 exosome-like vesicles. J Biol Chem. 2007;282(13):9591-9. Epub 2007/02/06. 
 
65. Robinson MS, Kreis TE. Recruitment of coat proteins onto Golgi membranes in 
intact and permeabilized cells: effects of brefeldin A and G protein activators. Cell. 
1992;69(1):129-38. Epub 1992/04/03. 
 
66. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of 
exosomes from cell culture supernatants and biological fluids. Current protocols in cell 
biology / editorial board, Juan S Bonifacino  [et al]. 2006;Chapter 3:Unit 3 22. Epub 
2008/01/30. 
 
67. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. 
Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 
2012;14(7):677-85. Epub 2012/06/05. 
 
68. Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, et al. 
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. 
Oncotarget. 2015. Epub 2015/05/07. 
 
69. Cantin R, Diou J, Belanger D, Tremblay AM, Gilbert C. Discrimination between 
exosomes and HIV-1: Purification of both vesicles from cell-free supernatants. Journal of 
Immunological Methods. 2008;338(1-2):21-30. 
 
70. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. 
Science. 2001;294(5543):862-4. Epub 2001/10/27. 
19 
 
 
71. Ambros V, Lee RC, Lavanway A, Williams PT, Jewell D. MicroRNAs and other 
tiny endogenous RNAs in C. elegans. Curr Biol. 2003;13(10):807-18. Epub 2003/05/16. 
 
72. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 
2004;116(2):281-97. Epub 2004/01/28. 
 
73. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of 
mammalian microRNA host genes and transcription units. Genome Res. 
2004;14(10A):1902-10. Epub 2004/09/15. 
 
74. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human 
microRNAs. Nat Struct Mol Biol. 2006;13(12):1097-101. Epub 2006/11/14. 
 
75. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha 
initiates microRNA processing. Nature. 2003;425(6956):415-9. 
 
76. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A 
cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 
small temporal RNA. Science. 2001;293(5531):834-8. Epub 2001/07/14. 
 
77. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate 
ribonuclease in the initiation step of RNA interference. Nature. 2001;409(6818):363-6. 
Epub 2001/02/24. 
 
78. Joshi SR, McLendon JM, Comer BS, Gerthoffer WT. MicroRNAs-control of 
essential genes: Implications for pulmonary vascular disease. Pulmonary circulation. 
2011;1(3):357-64. Epub 2011/12/06. 
 
79. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, et al. A robust 
methodology to study urine microRNA as tumor marker: microRNA-126 and 
microRNA-182 are related to urinary bladder cancer. Urol Oncol. 2010;28(6):655-61. 
 
80. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. 
Salivary microRNA: discovery, characterization, and clinical utility for oral cancer 
detection. Clin Cancer Res. 2009;15(17):5473-7. Epub 2009/08/27. 
 
81. Kosaka N, Izumi H, Sekine K, Ochiya T. microRNA as a new immune-regulatory 
agent in breast milk. Silence. 2010;1(1):7. Epub 2010/03/17. 
 
82. Wang Y, Sheng G, Juranek S, Tuschl T, Patel DJ. Structure of the guide-strand-
containing argonaute silencing complex. Nature. 2008;456(7219):209-13. Epub 
2008/08/30. 
 
83. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. 
MicroRNAs are transported in plasma and delivered to recipient cells by high-density 
lipoproteins. Nat Cell Biol. 2011;13(4):423-33. 
20 
 
 
84. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable 
in serum and saliva is concentrated in exosomes. PLoS ONE. 2012;7(3):e30679. Epub 
2012/03/20. 
 
85. Atay S, Gercel-Taylor C, Taylor DD. Human trophoblast-derived exosomal 
fibronectin induces pro-inflammatory IL-1beta production by macrophages. Am J Reprod 
Immunol. 2011;66(4):259-69. Epub 2011/03/18. 
 
86. Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing 
exosomes. Journal of visualized experiments : JoVE. 2012(59):e3037. Epub 2012/01/20. 
 
87. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A 
reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT 
and invasion in cancer cells. EMBO Rep. 2008;9(6):582-9. Epub 2008/05/17. 
 
88. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-
mesenchymal transition and cancer cell migration by direct targeting of E-cadherin 
transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283(22):14910-4. Epub 
2008/04/16. 
 
89. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, et al. Biological 
functions of miR-29b contribute to positive regulation of osteoblast differentiation. 
Journal of Biological Chemistry. 2009;284(23):15676-84. Epub 2009/04/04. 
 
90. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. 
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone 
formation. Endocrinology. 2005;146(3):1226-35. Epub 2004/12/14. 
 
91. Rossi M, Pitari MR, Amodio N, Di Martino MT, Conforti F, Leone E, et al. miR-
29b negatively regulates human osteoclastic cell differentiation and function: 
implications for the treatment of multiple myeloma-related bone disease. J Cell Physiol. 
2013;228(7):1506-15. Epub 2012/12/21. 
 
92. Baier SR, Nguyen C, Xie F, Wood JR, Zempleni J. MicroRNAs are absorbed in 
biologically meaningful amounts from nutritionally relevant doses of cow’s milk and 
affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell 
cultures, and mouse livers. J Nutr. 2014;144:1495-500. 
 
93. Reinhardt TA, Lippolis JD, Nonnecke BJ, Sacco RE. Bovine milk exosome 
proteome. Journal of proteomics. 2012;75(5):1486-92. 
 
94. Zonneveld MI, Brisson AR, van Herwijnen MJ, Tan S, van de Lest CH, Redegeld 
FA, et al. Recovery of extracellular vesicles from human breast milk is influenced by 
sample collection and vesicle isolation procedures. Journal of extracellular vesicles. 
2014;3. Epub 2014/09/11. 
21 
 
 
95. Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, et al. Exogenous plant 
MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom 
regulation by microRNA. Cell Res. 2012;22(1):107-26. Epub 2011/09/21. 
 
96. Snow JW, Hale AE, Isaacs SK, Baggish AL, Chan SY. Ineffective delivery of 
diet-derived microRNAs to recipient animal organisms. RNA Biol. 2013;10(7):1107-16. 
Epub 2013/05/15. 
 
97. Dickinson B, Zhang Y, Petrick JS, Heck G, Ivashuta S, Marshall WS. Lack of 
detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol. 
2013;31(11):965-7. Epub 2013/11/12. 
 
98. Chen X, Zen K, Zhang CY. Reply to Lack of detectable oral bioavailability of 
plant microRNAs after feeding in mice. Nat Biotechnol. 2013;31(11):967-9. Epub 
2013/11/12. 
 
99. Wang K, Li H, Yuan Y, Etheridge A, Zhou Y, Huang D, et al. The complex 
exogenous RNA spectra in human plasma: an interface with human gut biota? PLoS 
ONE. 2012;7(12):e51009. Epub 2012/12/20. 
 
100. Yu B, Yang Z, Li J, Minakhina S, Yang M, Padgett RW, et al. Methylation as a 
crucial step in plant microRNA biogenesis. Science. 2005;307(5711):932-5. Epub 
2005/02/12. 
 
101. Yang J, Farmer LM, Agyekum AA, Hirschi KD. Detection of dietary plant-based 
small RNAs in animals. Cell Res. 2015;25(4):517-20. Epub 2015/02/28. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
 
 
 
CHAPTER 2 
THE TRANSPORT OF BOVINE MILK 
EXOSOMES BY HUMAN COLON 
CARCINOMA CACO-2 CELLS AND RAT 
SMALL INTESTINAL IEC-6 CELLS 
 
  
23 
 
 
Transport of Bovine Exosomes by Human Colon Carcinoma Caco-2 cells and Rat 
Small Intestinal IEC-6 Cells 1-2 
Tovah Wolf 4, Scott R. Baier,4 Janos Zempleni*4 
Last names are underlined 
4Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, 
NE;  
*Corresponding Author: Janos Zempleni; jzempleni2@unl.edu; 316C Leverton Hall, 
Lincoln, NE 68583, USA 
Running Title: Uptake of Bovine Exosomes in human and rat cells.  
1 Supported by fund provided through NIH (1P20GM104320), NIFA (2015-67017-
23181), USDA (multistate grant W3002), the Gerber Foundation, the Egg Nutrition 
Center, and the University of Nebraska Agricultural Research Division (Hatch Act). 
2Author disclosures: T. Wolf, S. R. Baier, and J. Zempleni, no conflicts of interest. 
 
Abbreviations used: Vmax, maximal rate of exosome uptake; Km is the concentration of 
exosomal protein required to half-saturate the rate of maximum transport under 
experimental conditions; miR, microRNA; EV, extracellular vesicles;  qPCR, quantitative 
real-time polymerase chain reaction; RUNX2, runt-related transcription factor 2; ZEB1, 
zinc finger E-box binding homeobox 1. 
*To whom correspondence should be addressed. E-mail: jzempleni2@unl.edu 
Authors last names: Wolf, Baier, Zempleni
   24 
 
 
Abstract 
We have reported that microRNAs (miRNAs, miRs) in bovine milk regulate human 
genes. In milk, many miRNAs are encapsulated in exosomes, thereby conferring 
protection against degradation and a pathway for intestinal transport of miRNAs. We 
hypothesized that the uptake of bovine exosomes in human intestinal colon carcinoma 
Caco-2 cells and rat primary small intestinal IEC-6 cells is mediated by endocytosis. 
Transport studies were carried out using fluorophore-labeled exosomes purified from 
bovine milk. The transport of bovine exosomes exhibited saturation kinetics at 37°C 
(Km= 55.5±48.6 µg/200 µL, Vmax= 0.083±0.057 ng exosomal protein x 81,750 cells
−1 x 
hr−1) and decreased by 60% if transport was measured at 4°C in Caco-2 cells, consistent 
with carrier-mediated transport. Inhibitors of vesicle trafficking and carbohydrate 
competitors caused a 62-85% and 61-83% decrease, respectively, in exosome transport, 
consistent with cellular transport of bovine exosomes by endocytosis that depends on 
surface glycoproteins in Caco-2 cells. Similar patterns were observed in IEC-6 cells. 
When milk exosomes at a concentration of five times the Km were added to the upper 
chamber in transwell plates, Caco-2 cells accumulated miR-29b in the lower chamber, 
whereas reverse transport was minor.  We conclude that the uptake of bovine milk 
exosomes is mediated by endocytosis and depends on cell and exosome surface 
glycoproteins in human and rat intestinal cells.  
 
Key words: endocytosis; epithelial cell; extracellular vesicles; milk exosomes; bovine 
milk exosomes; uptake    
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INTRODUCTION  
The literature is well established that many cell types shed small vesicles into the 
extracellular space. Evidence suggests that exosomes mediate the transfer of microRNA 
(miRNA) between cells (1, 2). Our lab is the first to show that humans absorb meaningful 
quantities of mircoRNA-29b (miR-29b) and miR-200c from nutritionally relevant 
amounts of cow’s milk (3). Baier et al. also showed these miRNAs can affect expression 
in vitro, and that endogenous synthesis does not compensate for dietary miRNA loss in 
mice (3). MiR-29b is moderately abundant in cow’s milk, and plays a role in bone health 
(4) by repressing runt-related transcription factor 2 (RUNX2) inhibitors (5, 6), and as a 
result increases bone mineral density (7). MiR-200c is highly abundant in cow’s milk, 
and plays a role in cancer prevention by inhibiting the transcription factor zinc finger E-
box binding homebox 1 (ZEB1), thereby limiting epithelial-to-mesenchymal transition 
(8, 9).  
 Mature microRNAs (miRNAs) are small noncoding RNAs that typically bind to 
the 3’ UTR of target mRNAs, leading to mRNA break down or translational delay (10, 
11). The emerging evidence of human miRNAs modulating human genes has sparked an 
interest in dietary miRNAs to see if they also play a role in human health. Many 
microRNAs in milk are protected against degradation (12) by encapsulation in exosomes 
(13, 14). In 2007, it was discovered that exosomes carry mRNA and miRNA (15). In this 
study it was demonstrated that a human mast cell line expressed mouse specific proteins 
after treatment with mouse exosomal mRNA. This important finding indicated that 
mRNA transported via the exosomes is translated and may hold importance in overall 
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cell function (15). The aim of our study was to determine mechanisms of milk exosome 
cellular uptake. This study can help provide further evidence if food miRNAs protected 
by exosomes can gain entry into human colon carcinoma Caco-2 and rat IEC-6 primary 
small intestinal cells. Cow’s milk contains 245 microRNAs (16) and bioinformatics 
predictions suggest that 175 of those might interact with 11,199 human transcripts 
(unpublished data). 
 In this study we describe studies of human colon carcinoma Caco-2 cells (Caco-2) 
as a model system for studies of the uptake into human colon cells. We speculate that 
milk exosomes are absorbed in the small intestine, therefore we also use a rat small 
intestine epithelial cell (IEC-6) as a model as well. We hypothesize the uptake of bovine 
exosomes in human intestinal colon carcinoma Caco-2 cells and rat primary small 
intestinal IEC-6 cells is mediated by endocytosis. Here we will characterize the uptake 
kinetics of milk exosomes into Caco-2 and IEC-6 cells.  
 
METHODS AND MATERIALS  
 
Cell cultures. Human colon carcinoma Caco-2 cells were purchased from American Type 
Culture Collection and were used from passage 52-72 for experiments cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) containing 1% non-essential amino acids, 
10% fetal bovine serum (FBS), 1% L-glutamine, 100,000 U/L penicillin and 100 mg/L 
streptomycin. In select experiments, Caco-2 cells were cultured for 2 days in exosome-
depleted media obtained by ultracentrifugation of FBS at 120,000 x g for 6 hours. Cell 
media was replaced with fresh media every 2 to 3 days. Transport studies were conducted 
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at 75% confluence in 96-well plates and at 100% confluence in transwell plates. IEC-6 
primary rat small intestinal cells were obtained from ATCC at passage 14, and cultured 
as described for Caco-2 cells except that culture media contained 0.1 unit/mL bovine 
insulin and that no transwell studies were conducted due to the IEC-6 cells’ inability to 
form a tight monolayer. 
 
Milk exosome isolation and fluorophore conjugation. Skim cow’s milk was purchased 
in a local grocery store. The milk was centrifuged at 13,200 x g and 4°C for 30 minutes to 
remove somatic cells and debris. The supernatant was mixed 1:1 (by volume) with 250 
mM EDTA (pH 7.0) on ice for 15 minutes to precipitate milk casein(17). The suspension 
was ultracentrifuged at 100,000 x g and 4°C for 60 minutes (F37L-8x100 rotor; Thermo 
Scientific, USA) to remove precipitated protein, fat globules, and vesicles larger than 
exosomes. The clear supernatant was ultracentrifuged at 120,000 x g for 90 minutes at 
4°C to collect exosomes. The exosome pellet was re-suspended in a small volume of 
phosphate-buffered saline containing 0.01% sodium azide, filtered twice through a 0.22-
µm membrane filter, and stored at 4°C and -20°C if necessary. The exosomes were 
labeled with the fluorophore, FM 4-64 (Molecular Probes). One microliter of a stock 
solution of FM 4-64 (.986 mM/L) was added to 1 mL of exosome suspension, incubated 
for 15 minutes at 37°C and excess FM 4-64 was removed by ultracentrifugation at 
120,000 x g at 4°C for 90 minutes. 
Absence of aggregation and exosome purity was assessed as recommended by the 
International Society for Extracellular Vesicles (18). Briefly, absence of exosome 
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aggregation was confirmed using transmission electron microscopy (Hitachi H7500, 
Japan) in the Microscopy Core Facility in the University of Nebraska-Lincoln (Fig. 1A). 
ImageJ (http://imagej.nih.gov/ij/index.html) was used to analyze the exosome size 
distribution. Exosome purity and identity was confirmed using whole protein extracts 
from exosomes and gel electrophoresis (10 µg protein/lane) as described previously (19). 
Membranes were probed using mouse anti-bovine CD63 (AbD Serotec, UK) as a marker 
for exosomes, rabbit antiserum to bovine alpha s1-casein as a marker for the animal 
species of exosome origin, and goat anti-bovine histone H3 (Santa Cruz Biotechnology, 
USA) as a negative control (all at 1,000-fold dilutions). Bands were visualized using an 
Odyssey infrared imaging system (Licor, Inc.) and IRDye 800CW-labeled secondary 
antibodies at a 50,000-fold dilution (Fig. 1B).  
 
Transport studies. Caco-2 cells and IEC-6 cells were seeded at a density of 20,000 cells 
and 7,000 cells per well, respectively, in 96-well plates and allowed to adhere for 48 
hours. Transport studies were conducted using FM4-64 labeled exosomes using 3-110 μg 
exosomal protein/well (Caco-2 cells) or 27-652 μg exosomal protein/well (IEC-6 cells) 
and incubating cells for periods of time described in Results; blanks were created using 
solvent. Assays were calibrated by quantifying the fluorescence of a known mass of 
exosomes labeled with FM 4-64. When indicated, cells or exosomes were treated with 
100 μg/mL proteinase K (Caco-2 cells) to remove surface proteins, 10 μg/mL of the 
endocytosis inhibitor cytochalasin D, 20 μg/mL of brefeldin A to inhibit vesicle 
trafficking, and 150 mmol/L of the carbohydrate competitors D-glucose or D-galactose 30 
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minutes before initiation of transport studies and continuing for the duration of transport 
studies. IEC-6 cells did not survive proteinase K treatment. Therefore, surface proteins 
were removed by treating IEC-6 cells and exosomes using 0.105 mmol/L for five and 30 
minutes, respectively, at room temperature. Exosome uptake was analyzed by measuring 
the cell fluorescence at 515 nm (excitation) and 640 nm (emission) using a Biotek 
FLx800 plate reader and Gen5 data analysis software (BioTek, Winooski, VT). 
Fluorescence readings were corrected for cell autofluoresence by subtracting signals 
measured in cells incubated with exosome-depleted media. Transport kinetics were 
modeled using the Michaelis-Menten equation and non-linear regression; modeling was 
conducted using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA). 
In transwell studies, Caco-2 cells were seeded at a density of 9,000 cells per well 
and 75 μL media in 96-well polycarbonate plates with a pore size of 0.4 μm (EMD 
Millipore, Billerica, MA), and allowed to grow a differentiated monolayer for 21-24 days 
(20). Caco-2 cell monolayer integrity was formally confirmed using the Lucifer Yellow 
(LY) rejection assay according to the manufacturer’s instructions at a final concentration 
of 60 μmol/L (20). LY fluorescence was measured in the transwell apical and basolateral 
chambers after one hour of incubation at 37°C (480 nm excitation, 530 nm for emission). 
In parallel experiments, Caco-2 cells were cultured in exosome-depleted media to which 
milk exosomes were added back to produce either a concentration of 275 μg/100 μL 
exosomal protein in the upper, apical chamber or the lower, basolateral chamber. 
Controls were cultured in exosome-depleted media. Aliquots of media were collected 
from the upper chamber and bottom chamber after two hours of incubation for analysis of 
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miRNAs. Twenty-five attomoles of internal standard (miSPIKE Synthetic RNA, IDT 
Technologies) were added to samples prior to miRNA extraction using the nucleospin 
miRNA plasma kit (Macherey-Nagel). The concentration of miR-29b in transwell 
chambers was measured by quantitative real-time PCR, using miScript II RT kit, miScript 
SYBR Green (Qiagen), and miRNA-specific primers (Table 2) as described previously 
(3). Values were corrected for the internal standard to normalize for extraction efficiency. 
 
Statistics. Homogeneity of variances was assessed using the Brown-Forsythe test (21, 
22). The data variation for IEC-6 cells was heterogenous, i.e., those data were log 
transformed prior to statistical analysis. Statistical significance of differences among 
treatment groups was assessed using one-way ANOVA and Dunnett’s test for post hoc 
comparisons between treatment groups and control. Analyses were performed using 
GraphPad Prism. Differences were considered significant if P<0.05. Results were 
presented as means ± S.D. and represent independent biological replicates. 
 
RESULTS 
 
 
Time course. In Caco-2 cells, exosome uptake at 37°C was linear for up to 120 minutes if 
transport was measured using non-saturating substrate concentrations, i.e., 110 µg 
exosomal protein/200 μL (Fig. 2A): y=0.001159x + 0.01355 (r2=0.969). In IEC-6 cells, 
exosome uptake at 37°C was linear for only up to 60 minutes if transport was measured 
using non-saturating substrate concentrations, i.e., 55 µg/200 µL (Fig. 2B): y=0.003298x 
+ 0.03304 (r2=0.754). Subsequent transport studies were conducted using incubation 
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times of 60 minutes and 30 minutes for Caco-2 cells and IEC-6 cells, respectively. 
 
Transport kinetics. In both Caco-2 and IEC-6 cells, the uptake of bovine exosomes was 
mediated by saturable transport mechanisms. Transport kinetics were modeled using the 
Michaelis-Menten equation. In Caco-2 cells, Km and Vmax were 55.5±48.6 µg exosomal 
protein/200 µL medium and 0.083±0.057 ng exosomal protein x 81,750 cells−1 x hr−1, 
respectively, at 37°C (r2=0.746; Fig. 3A). In IEC-6 cells, Km and Vmax were 152.4 ±39.47 
µg/200 µL and 0.140±0.0133 ng exosomal protein x 36,375 cells−1 x 30 min−1, 
respectively, at 37°C (r2=0.559; Fig. 3B). When the incubation temperature was 
decreased from 37°C to 4°C, the transport rate decreased from 100±56% to 54±13% 
using a substrate concentration of 55.5 µg exosomal protein/200 µL in Caco-2 cells 
(P<0.05; n=3). Likewise, when the incubation temperature was decreased from 37°C to 
4°C, the transport rate decreased from 100±11% to 44±25% using a substrate 
concentration of 153 µg exosomal protein/200 µL in IEC-6 cells (P<0.05; n=3). 
Subsequent transport studies were conducted using substrate concentrations of 55 µg/200 
µL and 153 µg/200 µL in Caco-2 cells and IEC-6 cells, respectively, except for transwell 
studies. 
 
Roles of surface glycoproteins and endocytosis. The uptake of bovine milk exosomes 
into human and rat intestinal cells depended on surface proteins on both exosomes and 
cells. When surface proteins were removed from exosomes or Caco-2 cells were 
treatment with proteinase K, exosome uptake decreased to 32±25% and 18±16% of 
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controls (P<0.05, n=3) (Fig. 4A). These observations are consistent with previous reports 
that the cellular uptake of exosomes is initiated by protein/protein interactions, leading to 
vesicle uptake by endocytosis (23-25). When IEC-6 cells were treated with trypsin, 
exosome uptake decreased to 82±8% of controls (P<0.05, n=3) (Fig. 4C), indicating that 
proteins containing amino lysine and arginine on the cell surface may be involved in 
bovine milk exosome uptake. When Caco-2 cells were treated with inhibitors of 
endocytosis (cytochalasin D), intracellular vesicle trafficking (brefeldin A), or 
carbohydrate competitors the uptake of exosomes decreased to less than 50% of controls 
(Fig. 4B). Carbohydrate competitors were equally effective in decreasing exosome 
uptake into Caco-2 cells. The effects of these inhibitors and competitors were similar in 
IEC-6 cells, although treatments were not statistically significant (P=0.11, n=6) (Fig. 
4D). 
 
MiRNA sorting in the intestinal mucosa and reverse transport. When Caco-2 cells were 
provided with exosome-supplemented media (275 µg/100 μL) in the apical chamber and 
incubated for two hours, the concentrations of miR-29b in the basolateral chamber 
increased from 0.018±0.03 fmol/L to 0.094±0.16 fmol/L (P<0.05). When exosomes were 
provided with exosome-supplemented media (275 µg/100 μL) in the basolateral chamber 
and incubated for two hours, no concentration gradient was detected in the two chambers, 
suggesting minimal reverse transport under the experimental conditions: 0.067±0.068 
miR-29b fmol/L in the basolateral chamber compared to 0.066±0.11 fmol/L miR-29b in 
the apical chamber. Caco-2 cells formed a tight monolayer, judged by a Lucifer yellow 
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rejection percentage of 99.7±0.19%. 
 
DISCUSSION 
 Exosomes are found in many biologial fluids. In the past decade, research has been 
focused on but not limited to those found in urine (26, 27), salvia (28), blood  (29, 30 ), 
and breast milk (13, 31). While much has been discovered regarding exosomes, studies 
on mechanisms of intestinal transport of dietary exosomes are lacking. By understanding 
the uptake kinetics of bovine milk exosomes, this study provides the foundation to further 
explore the mechanism of bovine exosomes in regards to human health.  Here we provide 
evidence that bovine milk exosomes are absorbed into human colon carcinoma Caco-2 
cells and IEC-6 RAT small intestinal cells.  
 Evidence continues to emerge surrounding miRNA’s and their role in human 
health (8, 32, 33). The theory of deitary miRNA absorbance into the human intestinal 
muscosa and inducing biological activity in humans continues to gain evidence (3, 34-
36). In contrast to plant microRNAs, many mammalian microRNAs are protected against 
degradation (12) by encapsulation in microvesicles such as exosomes (13, 14, 37). It has 
become a controversial topic in the science community if plant miRNAs can in fact effect 
human gene expression (3, 38-41). In contrary, a recent report suggests that another 
animal product, eggs in nutritionally relevant amounts, can cause a 100% increase in 
plasma miRNAs (36). 
 By using inhibitors of vesicle trafficking and a broad-spectrum proteinase, and by 
measuring uptake at 4°C and 37°C, we provide evidence that uptake of bovine milk 
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exosomes is a carrier-mediated process in human intestinal cells and that glycoproteins 
on the milk exosomes and intestinal cells are involved. High sucrose concentrations have 
been associated with decreased levels of receptor-mediate endocytosis (42). By 
increasing the levels of glucose and galactose, it’s possible that the hyperosmolar state 
decreased the uptake of milk exosomes into Caco-2 cells, indicating bovine milk 
exosomes depend on endocytosis to be taken into the cell. We also think it’s possible that 
glucose and galactose may be acting as carbohydrate competitors with milk exosomes.   
 There are some uncertainties associated with our studies of bovine milk exosomes 
and will need to be revisited in future studies. First, FM4-64 might alter the structure of 
bovine EVs. We are not able to overcome this obstacle at this time. Second, FM4-64 is 
believed to fluoresce intensely when inserted into the outer leaflet of the surface 
membrane (43), so it’s possible that the bovine exosomes are not fully internalized in the 
cell. We find this to be an unlikely possibility due to a study from an independent 
laboratory suggesting that milk exosomes enter the mouse circulation intact by crossing 
the intestinal mucosa without re-packaging (35). We will carry out future studies to 
determine if we also can come to this conclusion. Lastly, it is not yet established if 
surface proteins in human and rat cells can recognize exosomes from other species.  
  Because low Km is associated with a higher affinity, we can conclude bovine 
exosomes is higher in human Caco-2 cells than rat IEC-6 cells. One could speculate that 
the bovine surface glycoproteome is more compatible with human cells than it is with 
rats. Current studies in our laboratory include characterization of the glycoproteins 
involved in bovine milk exosome transportation. In contrast, the capacity for transport is 
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higher in rat IEC-6 cells compared with human Caco-2 cells. One would expect that with 
more cells, the transport rates would be higher. When using half as many IEC-6 cells, the 
differences become more dramatic between transport rates. This makes logical sense 
based on the absorption kinetics of humans absorbing milk microRNA (3). This study out 
of our laboratory provided the evidence to propose that the upper intestine is the primary 
site of milk exosome absorption (3), and we validated it with the IEC-6 cell line in this 
study.  
Looking forward, the use of milk exosomes may be a promising vehicle for the 
oral delivery of drugs. Exosomes can be harvested from cells, but milk proves 
advantageous due to the large quantities that can be obtained and the practicality when it 
comes to the cost and availability. Cell cultures are often from cancer or mutant cells 
which might run the risk of promoting malignant transformation of cells in subjects 
treated with such vesicles (44).  
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Figure 1 
Electron microscopy and western blot. 
(A) Electron microscopy images: large field image (15,000 x magnification) and single 
exosomes (60,000X magnification).  
(B) Western Blot A: anti-C63 (exosome positive control), B: anti-casein (bovine positive 
control), C: anti-histone H3 (negative control). All samples were run on the same gel but 
the membrane had to be cut to allow for probing with distinct antibodies. 
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Figure 2 
 (A) Exosome uptake into human colon carcinoma Caco-2 cells as a function of time at a 
concentration of 110 µg exosome protein/200 µL medium and temperature of 37°C 
(n=6.) 
 (B) Exosome uptake into rat primary intestinal IEC-6 cells as a function of time at a 
concentration of 55 µg exosome protein/200 µL medium and temperature of 37°C (n=3). 
All panels: Means±SD are reported. 
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Figure 3 
Saturation kinetics of bovine exosome transport in Caco-2 cells.  
(A) Exosome uptake into human colon carcinoma Caco-2 cells as a function of exosome 
protein dose in one hour at 37°C (n=6).  
(B) Exosome uptake into rat primary intestinal IEC-6 cells as a function of exosome 
protein dose in 30 hour at 37°C (n=3). All panels: Means±SD are reported.  
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Figure 4 
Effects of inhibitors of endocytosis and vesicle trafficking, and carbohydrate competitors 
on the uptake of bovine exosomes in human and rat intestinal cells.  
(A) Treatment of bovine exosomes or Caco-2 cells with proteinase K prior to analysis of 
transport rates. (n=3).  
(B) Exosome transport in Caco-2 cells treated with cytochalasin D (Cyt D), brefeldin A 
(BFA), or in the presence of carbohydrate competitors (n=5).  
(C) Treatment of bovine exosomes or IEC-6 cells with trypsin prior to analysis of 
transport rates (n=3).  
(D) Exosome transport in IEC-6 cells treated with Cyt D, BFA, or in the presence of 
carbohydrate competitors (n=6).  
All panels: Means±SD are reported; *p<0.05 vs control. 
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Table 1 
Quantitative PCR Primers Used to Quantify Gene Expression   
microRNA Forward Primer Sequence 5 – 3’ 
miSpike CTC AGG ATG GCG GAG CGG TCT 
miR-29b GTA GCA CCA TTT GAA TCA GTG TT  
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CHAPTER 3 
 
CONCLUSIONS 
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FUTURE STUDIES & CONCLUSION 
 Moving forward our lab is currently conducting a study analyzing phenotypic 
effects potentially due to microRNA provided by the diet. Mice are being fed an exosome 
plus diet, where microRNAs are present, or an exosome minus diet, in which microRNAs 
are depleted through sonication. Plasma and a number of different tissues will be 
analyzed at different stages in life. The success of breeding and offspring survival will be 
analyzed as well.  Our lab will also test feeding human adults soy infant formula and the 
same soy infant formula but supplemented with bovine milk exosomes. We predict the 
miRNA plasma levels will not change following consumption of soy formula alone, but 
when supplemented with bovine exosomes, may result in plasma miRNA increases 
similar to our prior study (1).  
 Many questions remain unanswered about extracellular vesicles, and much 
research is still needed, but so far, the future of extracellular vesicles in drug delivery is 
looking promising (2, 3). A remarkable study recently published created a treatment by 
loading exosomes with a catalase, a potent antioxidant, for the treatment of Parkinson’s 
Disease in mice (2).  A clinical trial currently recruiting participants will access if plant 
exosomes loaded with curcumin can effectively deliver curcumin to colon cancer and 
normal colon mucosa tissues as a dietary supplement (4).  
 Technical aspects of EV research, such as storage, isolation, and other factors are 
being explored to determine the best technique for harvesting and preserving EVs (5-7).  
Mammal and food derived EVs currently have no established nomenclature for 
classification and isolation procedures (8). This study, and many others, is just the 
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beginning of a path that will perhaps lead to improved insight on drug and nutrient 
delivery systems.   
  MicroRNAs have been implicated in many aspects of human health and disease 
including bone health, inflammatory bowel disease, metabolic syndrome (9-12) cancer 
(13), and cystic fibrosis (14-16). Though it is important to note that some miRNAs may 
have adverse effects (17-19). More in-depth studies to determine if dietary microRNAs 
can survive and pass the human gastrointestinal tract are needed. As the great Frenchmen 
Brillat-Savarin once said, “Tell me what you eat, and I will tell you what you are.” This 
may continue to ring true with even deeper meaning than initially thought if dietary 
microRNAs from other species can indeed impact gene expression in humans.  
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